Brokerages Set Savaria Co. (TSE:SIS) Price Target at C$33.33

Savaria Co. (TSE:SIS) has earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is C$33.33.

A number of equities research analysts have issued reports on the stock. National Bank Financial lifted their target price on shares of Savaria from C$30.50 to C$37.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Scotia upped their price target on shares of Savaria from C$30.00 to C$33.00 and gave the stock a “sector outperform” rating in a research note on Thursday, April 16th. Stifel Nicolaus increased their price objective on Savaria from C$29.00 to C$31.00 and gave the stock a “buy” rating in a report on Wednesday, April 8th. ATB Cormark Capital Markets lifted their price objective on Savaria from C$32.00 to C$35.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. Finally, Raymond James Financial boosted their target price on Savaria from C$32.00 to C$33.00 and gave the company an “outperform” rating in a research note on Wednesday, April 15th.

Insider Buying and Selling

In related news, Director Jean-Louis Chapdelaine sold 25,000 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of C$27.73, for a total transaction of C$693,250.00. Following the completion of the transaction, the director owned 100,000 shares of the company’s stock, valued at approximately C$2,773,000. The trade was a 20.00% decrease in their position. Also, Director Peter Allen Drutz sold 15,264 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of C$27.48, for a total value of C$419,454.72. Following the completion of the sale, the director directly owned 104,987 shares of the company’s stock, valued at C$2,885,042.76. This represents a 12.69% decrease in their ownership of the stock. In the last three months, insiders have sold 62,500 shares of company stock worth $1,761,124. 17.45% of the stock is currently owned by company insiders.

Savaria Price Performance

Shares of SIS stock traded up C$0.74 during mid-day trading on Friday, hitting C$31.09. 105,880 shares of the stock traded hands, compared to its average volume of 166,992. Savaria has a twelve month low of C$19.41 and a twelve month high of C$31.22. The firm has a market cap of C$2.23 billion, a price-to-earnings ratio of 28.26, a price-to-earnings-growth ratio of 42.72 and a beta of 1.03. The company’s 50-day simple moving average is C$28.99 and its 200-day simple moving average is C$26.86. The company has a debt-to-equity ratio of 31.42, a quick ratio of 0.91 and a current ratio of 1.71.

Savaria (TSE:SIS) last released its quarterly earnings data on Wednesday, May 6th. The company reported C$0.31 earnings per share for the quarter. The business had revenue of C$235.55 million during the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%. As a group, equities research analysts expect that Savaria will post 1.2048518 earnings per share for the current year.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.